Although no differences were observed in fasting glucose, insulin or C-peptide levels, both 35 treated groups displayed an impaired glucose excursion during both glucose and insulin 36 tolerance tests. These results suggest glucose intolerance and insulin resistance. 37 An increase in glucose-6-phosphatase protein levels (68%, p<0.05) and in protein-tyrosine 
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Immunosuppressive therapy is used in the treatment of autoimmune diseases and after organ Relative mRNA levels were measure by RT-PCR using specific primers for each target 
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GTT, ITT, glucose, insulin, C-peptide in serum and glycogen measurements in liver
248
GTTs were performed at the end of the treatments. insulin sensitivity was impaired in the CsA treated animals (Fig 1B) . For the SRL group, a 257 significant increase in blood glucose levels during an ITT was only observed at 60 min (3.76 258 ± 0.08 mmol/l) compared to the vehicle group (2.65 ± 0.14 mmol/l, p<0.05). Although, no 259 significant differences were found in the AUC for the GTT (Fig. 1A) , the AUC for the ITT 260 was 67% (p<0.001) and 55% (p<0.001) increased in CsA and SRL-treated groups, compared 261 to vehicle (Fig. 1 B) . This result further confirmed reduced insulin sensitivity for both the 
Glucose clearance rate in the urine
269
Animals in the SRL group exhibited a trend for an increased glucose clearance rate (0.14 270 ±0.04 ml/h/rat), compared with the CsA (0.06 ± 0.01 ml/h/rat; p=0.06) but no significant 271 difference compared with the vehicle-treated group with the present study power (0.09 ± 0.01 272 ml/h/rat). This result suggests that an excess of glucose is present in the urine flux and is 273 being expelled via the kidneys (Fig. 1F) .
A c c e p t e d M a n u s c r i p t Thr308 phosphorylation was impaired. However, the total protein levels of these markers 329 were not altered by either treatment (Fig. 5 B) . CsA-treated rats might be related with a reduced amount of GLUT4 in the plasma membrane 
